Tuesday, March 31, 2020

Biocon's Malaysia unit gets EIR from USFDA

Biocons Insulin manufacturing facility in Malaysia receives EIR from USFDA with Voluntary Action Indicated (VAI) classification, inspection stands closed.

from India Infoline News Service https://ift.tt/2UXzMkq
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)